Pharmacophore an International Research Journal
Acute respiratory tract infections are considered to be triggers of cardiovascular diseases. These include influenza, bacterial pneumonia, and respiratory syncytial infection. If at the time of the disease, the patient has concomitant cardiovascular pathology, then the probability of the development and progression of the infectious process increases. The appearance of complications of cardiovascular diseases against the background of COVID-19 has turned into a pandemic. Most of the patients with the detected virus have cardiovascular diseases, which can lead to coronary heart disease, myocarditis, and other heart diseases even for a long time after recovery. Currently, there are no specific therapeutic strategies for the management of patients with post-covid syndrome. From the point of view of understanding the pathophysiological mechanisms and existing therapy algorithms in cardiology, several therapeutic strategies can be formulated: to control risk factors, including blood pressure, lipid levels, glucose, and obesity. In addition, it is necessary to recommend lifestyle changes and quitting smoking and alcohol, modification of physical activity, and nutrition. This article describes a clinical case - a 57-year-old man who has had COVID-19, including negative changes occurring in his body. The data of the conducted research are given.
